 | Eversheds Sutherland (US) LLP 700 Sixth Street, NW, Suite 700
D: +1 202.383.0805
harrypangas@ eversheds-sutherland.com |
May 25, 2018
Via EDGAR
Securities and Exchange Commission
Division of Investment Management
Attn: Dominic Minore, Esq.
100 F Street, N.E.
Washington, DC 20549
| Re: | Alcentra Capital Corporation |
Preliminary Proxy Statement on Schedule 14A filed on May 11, 2018
File No. 814-01064
Dear Mr. Minore:
On behalf of Alcentra Capital Corporation (the “Company”), set forth below are the Company’s responses to the oral comments provided by the staff of the Division of Investment Management (the “Staff”) of the Securities and Exchange Commission (the “Commission”) to the Company on May 15, 2018 relating to the Company’s preliminary proxy statement on Schedule 14A (File No. 814-01064), filed with the Commission on May 11, 2018 (the “Proxy Statement”). The Staff’s comments are set forth below in italics and are followed by the Company’s responses.
| 1. | Please confirm that all information required to be disclosed by Item 22(b)(11) of Schedule 14A has been included for each director in the Proxy Statement. |
Response: The Company confirms to the Staff that all information required to be disclosed by Item 22(b)(11) of Schedule 14A has been included for each director in the Proxy Statement.
* * *
Eversheds Sutherland (US) LLP is part of a global legal practice, operating through various separate and distinct legal entities, under Eversheds Sutherland. For a full description of the structure and a list of offices, please visit www.eversheds-sutherland.com.
| Mr. Dominic Minore May 25, 2018 Page 2 |
If you have any questions or additional comments concerning the foregoing, please contact the undersigned at (202) 383-0805.
| Sincerely, | |
| /s/ Harry S. Pangas | |
| Harry S. Pangas |
| cc: | David Scopelliti, Alcentra Capital Corporation |
Ellida McMillan, Alcentra Capital Corporation